Beyond TRIPS: Questioning the Effectiveness of the Global Intellectual Property Regime

An examination of how the TRIPS agreement extended patent protection over life-saving medicine into developing and least-developed countries, and whether its flexibilities (compulsory licensing, the Doha Declaration) actually deliver access to drugs. The conclusion resists the easy thesis: neither patent regimes nor corporate behavior alone explains the global health gap. The underlying issue is poverty.